Skip to main content Back to Top
Advertisement

1/30/2020

Latanoprost Ophthalmic Solution

Products Affected - Description

    • Latanoprost ophthalmic solution, Akorn, 0.005% (50 mcg/mL), 2.5 mL bottle, NDC 17478-0625-12 - discontinued

Reason for the Shortage

    • Akorn has discontinued latanoprost ophthalmic solution.
    • Bausch Health has latanoprost ophthalmic solution available.
    • Greenstone has latanoprost ophthalmic solution available.
    • Rising has latanoprost ophthalmic solution available.
    • Sandoz (Falcon) has latanoprost ophthalmic solution available.

Available Products

    • Latanoprost ophthalmic solution, Bausch Health, 0.005% (50 mcg/mL), 2.5 mL bottle, NDC 24208-0463-25
    • Latanoprost ophthalmic solution, Greenstone, 0.005% (50 mcg/mL), 2.5 mL bottle, NDC 59762-0333-02
    • Latanoprost ophthalmic solution, Rising Pharmaceuticals, 0.005% (50 mcg/mL), 2.5 mL bottle, NDC 64980-0516-25
    • Latanoprost ophthalmic solution, Sandoz, 0.005% (50 mcg/mL), 2.5 mL bottle, 3 count, NDC 61314-0547-03
    • Latanoprost ophthalmic solution, Sandoz, 0.005% (50 mcg/mL), 2.5 mL bottle, NDC 61314-0547-01

Updated

Updated January 30, 2020 by Rachael Freeman, PharmD, BCPS. Created January 3, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins